13
In September 2023, personalized cancer vaccines based on mRNA technology achieved phased results! BioNTech, a German company, has released clinical trial data for its mRNA vaccine targeting melanoma. The results show that the vaccine can effectively stimulate anti-tumor immune responses in patients, providing new ideas for cancer immunotherapy.
Latest News
